AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Travere Therapeutics, Inc.

$50.39 +$10.87 (+27.51%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$50.57
Day Range
$49.71$52.66
Year Range
$22.59$68.73
Market Cap
4.75B
AVG Volume
1.7M
Trailing/Forward PE
-111.98/17.61
PEG ratio
3.73
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TVTX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2591.33M
26 Q1536.2M
25 Q4490.73M
25 Q3435.83M
25 Q2333.87M
25 Q1273.53M
24 Q4233.18M
24 Q3203.45M
24 Q2177.64M
24 Q1155.72M
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TVTX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-43.46M
26 Q1-21.42M
25 Q4-25.55M
25 Q3-88.54M
25 Q2-169.06M
25 Q1-226.71M
24 Q4-321.55M
24 Q3-351.45M
24 Q2-145.91M
24 Q1-161.13M
Operating Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TVTX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-40.46M
26 Q1-57.06M
25 Q4-62.82M
25 Q3-91.13M
25 Q2-172.21M
25 Q1-226.61M
24 Q4-323.17M
24 Q3-345.28M
24 Q2-381.71M
24 Q1-418.61M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: TVTX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Nov 2026.

Travere Therapeutics, Inc.
TVTX
Stockpicker

Video analysis: TVTX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TVTX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.